We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Capstone Therapeutics Corp (MM) | NASDAQ:CAPS | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.25 | 0 | 01:00:00 |
Delaware
|
000-21214
|
86-0585310
|
||
(State or other jurisdiction of incorporation)
|
(Commission File Number)
|
(I.R.S. Employer
Identification No.)
|
1275 West Washington Street, Suite 101, Tempe, Arizona
|
85281
|
|
(Address of principal executive offices)
|
(Zip Code)
|
|
[ ]
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
[ ]
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
|
[ ]
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
|
[ ]
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Section 1 – Registrant’s Business and Operations
|
Section 3 – Securities and Trading Markets
|
Section 9 – Financial Statements and Exhibits
|
Exhibit No.
|
Description
|
4.1
|
Second Amendment to Rights Agreement, dated as of June 6, 2011, by and between Capstone Therapeutics Corp. and The Bank of New York.
|
99.1
|
Press release issued June 8, 2011.
|
Dated: June 8, 2011
|
CAPSTONE THERAPEUTICS CORP.
|
/s/ John M. Holliman, III
|
|
John M. Holliman
|
|
Executive Chairman
|
Exhibit No.
|
Description
|
4.1
|
Second Amendment to Rights Agreement, dated as of June 6, 2011, between Capstone Therapeutics Corp. and The Bank of New York.
|
99.1
|
Press release issued June 8, 2011.
|
1 Year Capstone Therapeutics Corp (MM) Chart |
1 Month Capstone Therapeutics Corp (MM) Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions